MoonLake Immunotherapeutics Board of Directors

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Dr. Jorge Santos da Silva

Dr. Jorge Santos da Silva

Co-Founder, CEO & Director

Mr. Oliver Daltrop Ph.D.

Mr. Oliver Daltrop Ph.D.

Chief Operations Officer

Ms. Nuala Brennan

Ms. Nuala Brennan

Chief Clinical Development Officer

Ms. Carla Bretes

Ms. Carla Bretes

Director Investor Relations & Business Development

Tino Anthamatten

Tino Anthamatten

Vice President of Marketing, Market Access & Pricing

Joana Cortez

Joana Cortez

Sr. Director Legal & Compliance

Mr. Nicolas Mosimann

Mr. Nicolas Mosimann

General Counsel

Dr. Kristian Reich

Dr. Kristian Reich

Co-Founder & Chief Scientific Officer

Mr. Matthias Bodenstedt

Mr. Matthias Bodenstedt

Chief Financial Officer

Luciana Marques

Luciana Marques

Director of HR, People & Culture

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments

Comment created.